Search - tctmd.com

Displaying 321 - 340 of 1417

Sort: Relevancy | Date

News Daily News

Even With No Restrictions on Fat Intake, Mediterranean Diet May Help Prevent Disease

Michael H. Wilson

July 19, 2016

News Daily News

Sitting Pretty: Only Prolonged Sedentary Time Linked With Incident CVD Risk

Michael O'Riordan

July 15, 2016

News Daily News

Galen Strohm Wagner, Who Helped Establish the Duke Databank for Cardiovascular Disease, Dies Age 76

Michael H. Wilson

July 14, 2016

News Daily News

AstraZeneca Strives to Block Generic Crestor as Observers Call Foul

Michael O'Riordan

July 13, 2016

News Daily News

MI Patients Who Develop Heart Failure Vulnerable to Higher Risk of Cancer

Michael H. Wilson

July 13, 2016

News Daily News

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

Michael O'Riordan

July 12, 2016

News Daily News

AHA Advises Physicians to Monitor Medications That Might Cause or Worsen Heart Failure

Michael H. Wilson

July 12, 2016

News Daily News

Amount of Calcium, Not Calcium Progression, May Be Best for Gauging CV Risk

Michael H. Wilson

July 07, 2016

News Daily News

TAVR 可用于治疗二尖瓣主动脉瓣狭窄，但与永久性起搏器植入率更高相关联

Michael O'Riordan

July 05, 2016

News Daily News

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Michael O'Riordan

July 05, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

News Daily News

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

Michael O'Riordan

July 05, 2016

News Daily News

Structured Exercise Program Can Help the Sedentary Elderly but Does Not Curb CV Events

Michael H. Wilson

July 05, 2016

News Daily News

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

Michael O'Riordan

June 30, 2016

News Daily News

FDA 顾问小组小范围建议使用糖尿病药物 empagliflozin 来改善 CVD 死亡率

Michael O'Riordan

June 30, 2016

News Daily News

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Michael O'Riordan

June 30, 2016

News Daily News

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Michael O'Riordan

June 29, 2016

News Daily News

FDA Warns of Class I Recall for HeartWare VAD Batteries

Michael O'Riordan

June 29, 2016

News Industry News

AtriCure Receives CE Mark for the AtriClip® PRO2 Device

June 29, 2016

News Daily News

Si se Tomaran Más INRA, podrían Salvarle la Vida a Casi 30.000 Pacientes Cada Año

Michael H. Wilson

June 28, 2016

Advertisement

Even With No Restrictions on Fat Intake, Mediterranean Diet May Help Prevent Disease

Sitting Pretty: Only Prolonged Sedentary Time Linked With Incident CVD Risk

Galen Strohm Wagner, Who Helped Establish the Duke Databank for Cardiovascular Disease, Dies Age 76

AstraZeneca Strives to Block Generic Crestor as Observers Call Foul

MI Patients Who Develop Heart Failure Vulnerable to Higher Risk of Cancer

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

AHA Advises Physicians to Monitor Medications That Might Cause or Worsen Heart Failure

Amount of Calcium, Not Calcium Progression, May Be Best for Gauging CV Risk

TAVR 可用于治疗二尖瓣主动脉瓣狭窄，但与永久性起搏器植入率更高相关联

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

Structured Exercise Program Can Help the Sedentary Elderly but Does Not Curb CV Events

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

FDA 顾问小组小范围建议使用糖尿病药物 empagliflozin 来改善 CVD 死亡率

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

FDA Warns of Class I Recall for HeartWare VAD Batteries

AtriCure Receives CE Mark for the AtriClip® PRO2 Device

Si se Tomaran Más INRA, podrían Salvarle la Vida a Casi 30.000 Pacientes Cada Año

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content